Skip to main content

Table 1 Summary of patients’ characteristics

From: Serum Hepcidin and GDF-15 levels as prognostic markers in urothelial carcinoma of the upper urinary tract and renal cell carcinoma

 

Urothelial Carcinoma

Renal Cell Carcinoma

Control

Metastases-free

Metastases

Metastases-free

Metastases

Number of Patients

31 (♂ 22, ♀ 9)

7 (♂ 4, ♀ 3)

50 (♂ 35, ♀ 15)

44 (♂ 30, ♀ 14)

21 (♂ 15, ♀6)

Age

69 [57.5, 73.5]

71 [70.5, 71.5]

65.2 [56.9, 73.2]

63.1 [55.3, 69.2]

66 [61, 73]

TNM classification

CIS, Ta, T1–3 N0, M0

Ta, T1–3 N+/M+

T1a-3c N0–1 M0

T1a-4 N0–2 M0–2

Hgb (g/dl)

F: 12.9 [10.9, 13.9]

M: 13.8 [13.2, 14.4]

F: 10.7 [10.6, 11.9]

M: 13.8 [12.5, 14.3]

F: 13.3 [12.8, 14.4]

M: 14.5 [12.8, 15.5]

F: 11.6 [10.7, 12.9] M: 14.2 [12.6, 14.7]

F: 13.6 [12.9, 14.2]

M: 14.9 [14.5, 15.9]

Hepcidin (ng/ml)

36.4 [19.1, 113.3]

59.6 [46.7, 110.8]

8.2 [4, 18.4]

18 [8.3, 35.3]

5.8 [3.9, 11.2]

GDF-15 (pg/ml)

2039.4 [1360.9, 3215.2]

4342.3 [3448, 6406.6]

934.6 [687.1, 1711.2]

1742.6 [989.1, 2690.1]

754.3 [601.3, 987.7]

Relapse

12

5

0

39